A Phase 1b Study of Vadastuximab Talirine (33A) in Combination with 7+3 Induction Therapy for Patients with Newly Diagnosed Acute Myeloid Leukemia (AML)

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Walter, R; Erba, H; Ravandi, F

Published Date

  • February 1, 2017

Published In

Volume / Issue

  • 96 /

Start / End Page

  • S69 - S69

Published By

Pages

  • 1

Electronic International Standard Serial Number (EISSN)

  • 1432-0584

International Standard Serial Number (ISSN)

  • 0939-5555